Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells.

Katsoulidis E, Mavrommatis E, Woodard J, Shields MA, Sassano A, Carayol N, Sawicki KT, Munshi HG, Platanias LC.

J Biol Chem. 2010 Dec 17;285(51):40333-41. doi: 10.1074/jbc.M110.151076. Epub 2010 Oct 18.


Interferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription.

Huang W, Zhou W, Saberwal G, Konieczna I, Horvath E, Katsoulidis E, Platanias LC, Eklund EA.

Mol Cell Biol. 2010 Oct;30(19):4575-94. doi: 10.1128/MCB.01595-09. Epub 2010 Aug 2.


Deregulation of Interferon Signaling in Malignant Cells.

Katsoulidis E, Kaur S, Platanias LC.

Pharmaceuticals (Basel). 2010 Feb 4;3(2):406-418. Review.


Role of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responses.

Katsoulidis E, Carayol N, Woodard J, Konieczna I, Majchrzak-Kita B, Jordan A, Sassano A, Eklund EA, Fish EN, Platanias LC.

J Biol Chem. 2009 Sep 11;284(37):25051-64. doi: 10.1074/jbc.M109.030445. Epub 2009 Jul 10.


Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals.

Kroczynska B, Kaur S, Katsoulidis E, Majchrzak-Kita B, Sassano A, Kozma SC, Fish EN, Platanias LC.

Mol Cell Biol. 2009 May;29(10):2865-75. doi: 10.1128/MCB.01537-08. Epub 2009 Mar 16.


Activation of protein kinase C{eta} by type I interferons.

Redig AJ, Sassano A, Majchrzak-Kita B, Katsoulidis E, Liu H, Altman JK, Fish EN, Wickrema A, Platanias LC.

J Biol Chem. 2009 Apr 17;284(16):10301-14. doi: 10.1074/jbc.M807254200. Epub 2009 Feb 11.


Akt and mRNA translation by interferons.

Kaur S, Katsoulidis E, Platanias LC.

Cell Cycle. 2008 Jul 15;7(14):2112-6. Epub 2008 May 8. Review.


Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.

Dolniak B, Katsoulidis E, Carayol N, Altman JK, Redig AJ, Tallman MS, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Platanias LC.

J Biol Chem. 2008 May 2;283(18):12034-42. doi: 10.1074/jbc.M708816200. Epub 2008 Feb 25.


Suppression of interferon (IFN)-inducible genes and IFN-mediated functional responses in BCR-ABL-expressing cells.

Katsoulidis E, Sassano A, Majchrzak-Kita B, Carayol N, Yoon P, Jordan A, Druker BJ, Fish EN, Platanias LC.

J Biol Chem. 2008 Apr 18;283(16):10793-803. doi: 10.1074/jbc.M706816200. Epub 2008 Feb 20.


Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway.

Carayol N, Katsoulidis E, Sassano A, Altman JK, Druker BJ, Platanias LC.

J Biol Chem. 2008 Mar 28;283(13):8601-10. doi: 10.1074/jbc.M707934200. Epub 2008 Jan 26.


Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.

Altman JK, Yoon P, Katsoulidis E, Kroczynska B, Sassano A, Redig AJ, Glaser H, Jordan A, Tallman MS, Hay N, Platanias LC.

J Biol Chem. 2008 Jan 25;283(4):1992-2001. Epub 2007 Nov 29.


Suppressive effects of statins on acute promyelocytic leukemia cells.

Sassano A, Katsoulidis E, Antico G, Altman JK, Redig AJ, Minucci S, Tallman MS, Platanias LC.

Cancer Res. 2007 May 1;67(9):4524-32.


Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cells.

Yoon P, Giafis N, Smith J, Mears H, Katsoulidis E, Sassano A, Altman J, Redig AJ, Tallman MS, Platanias LC.

Mol Cancer Ther. 2006 Nov;5(11):2815-23.


Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.

Giafis N, Katsoulidis E, Sassano A, Tallman MS, Higgins LS, Nebreda AR, Davis RJ, Platanias LC.

Cancer Res. 2006 Jul 1;66(13):6763-71.


Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide.

Kannan-Thulasiraman P, Katsoulidis E, Tallman MS, Arthur JS, Platanias LC.

J Biol Chem. 2006 Aug 11;281(32):22446-52. Epub 2006 Jun 8.


The p38 mitogen-activated protein kinase pathway in interferon signal transduction.

Katsoulidis E, Li Y, Mears H, Platanias LC.

J Interferon Cytokine Res. 2005 Dec;25(12):749-56. Review.


Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes.

Katsoulidis E, Li Y, Yoon P, Sassano A, Altman J, Kannan-Thulasiraman P, Balasubramanian L, Parmar S, Varga J, Tallman MS, Verma A, Platanias LC.

Cancer Res. 2005 Oct 1;65(19):9029-37.


Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells.

Kaur S, Parmar S, Smith J, Katsoulidis E, Li Y, Sassano A, Majchrzak B, Uddin S, Tallman MS, Fish EN, Platanias LC.

Exp Hematol. 2005 May;33(5):550-7.


Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells.

Parmar S, Smith J, Sassano A, Uddin S, Katsoulidis E, Majchrzak B, Kambhampati S, Eklund EA, Tallman MS, Fish EN, Platanias LC.

Blood. 2005 Oct 1;106(7):2436-43. Epub 2005 Mar 24.


Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells.

Parmar S, Katsoulidis E, Verma A, Li Y, Sassano A, Lal L, Majchrzak B, Ravandi F, Tallman MS, Fish EN, Platanias LC.

J Biol Chem. 2004 Jun 11;279(24):25345-52. Epub 2004 Mar 31.


Pyruvate carboxylase is a major bottleneck for glutamate and lysine production by Corynebacterium glutamicum.

Peters-Wendisch PG, Schiel B, Wendisch VF, Katsoulidis E, Möckel B, Sahm H, Eikmanns BJ.

J Mol Microbiol Biotechnol. 2001 Apr;3(2):295-300.


Facial and perioral molluscum contagiosum as a manifestation of HIV infection.

Kolokotronis A, Antoniades D, Katsoulidis E, Kioses V.

Aust Dent J. 2000 Mar;45(1):49-52.

Supplemental Content

Loading ...
Support Center